Sign up for free!
Get instant access to stock market data and news with our free APIs.
- Listing exchange
- NASDAQ Stock Exchange
- Day High
- Day Low
- Day Open
- Day Change
Latest news data for ADAG
Anti-CTLA-4 Monoclonal Antibodies Market Set to Register a Steady Revenue CAGR of 8.3% by 2031 | Growth Plus Reports
盤中速報 - Adagene Inc - ADR(ADAG-US)股價大漲至1.5500元，漲幅達6.9%
Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody ADG126 By Investing.com
Are Medical Stocks Lagging Adagene (ADAG) This Year?
Adagene Announces Poster Presentations on Anti-CTLA-4 SAFEbody®, ADG126, at Upcoming American Association for Cancer Research (AACR) Annual Meeting in April
Adagene Announces Interim Data Demonstrating Safety and Confirmed Clinical Responses of Anti-CTLA-4 SAFEbody® ADG126 up to 10 mg/kg with Repeat Cycles in Combination with Anti-PD-1 Therapy from Dose E
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session - Adagene (NASDAQ:ADAG), Adobe (NASDAQ:ADBE)
ADAG stock gains on clinical trial collaboration with Roche (NASDAQ:ADAG)
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer
Adagene Appoints Cuong Do to Board of Directors and Audit Committee